Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Recombinant therapeutic proteins, of which monoclonal antibodies (mAbs) represent the largest market, are used to treat diseases including cancer, blood and immune disorders. The cost and complexity of large-scale production and purification of mAbs translates to high cost of therapy. We hypothesise...

全面介紹

書目詳細資料
Main Authors: Antepowicz, A, Tan, A, Pringle, A, Hyde, S, Gill, D
格式: Conference item
出版: Mary Ann Liebert Inc 2016

相似書籍